Genomic Characterization of Response to Chemoradiation in Urothelial Bladder Cancer: CNCR-16-0635.R1

BACKGROUND: This study characterized the genetic landscape of chemoradiation treated urothelial carcinoma of the bladder (UCB), with the goal of identifying potential correlates of response. METHODS: Primary tumors with (n=8) or without (n=40) matched recurrent tumor from 48 non-metastatic high grad...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer
Asıl Yazarlar: DesaiMD, Neil B., ScottMPH, Sasinya N., ZaborMS, Emily C., ChaMD, Eugene K., HreikiMD, Joseph, SfakianosMD, John P., RamirezPhD, Ricardo, BagrodiaMD, Aditya, RosenbergMD, Jonathan E., BajorinMD, Dean F., BergerPhD, Michael F., BochnerMD, Bernard H., ZelefskyMD, Michael J., KollmeierMD, Marisa A., OstrovnayaPhD, Irina, Al-AhmadieMD, Hikmat A., SolitMD, David B., IyerMD, Gopa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115929/
https://ncbi.nlm.nih.gov/pubmed/27479538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30219
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller